Anakinra utilization in refractory pediatric CAR T-cell associated toxicitiesCaroline Diorio, Nirali N. Shah, Anant Vatsayan et al.|Blood Advances|2022Cited by 56
Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene ExpressionDavid A. Jacobsohn, Michael A. Pulsipher, Michael R. Loken et al.|Transplantation and Cellular Therapy|2018Cited by 44
Pathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantationMatt S. Zinter, Joseph L. DeRisi, Hisham Abdel‐Azim et al.|Nature Medicine|2024Cited by 19
Outcomes of pediatric patients with therapy-related myeloid neoplasmsAkshay Sharma, Marie de Tersant, Sujuan Huang et al.|Bone Marrow Transplantation|2021Cited by 12
Integrating pulmonary and systemic transcriptomes to characterize lung injury after pediatric hematopoietic stem cell transplantEmma Pearce, Matt S. Zinter, Erica Evans et al.|JCI Insight|2025Cited by 2